GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aligned Genetics Inc (XKRX:238120) » Definitions » Debt-to-Revenue

Aligned Genetics (XKRX:238120) Debt-to-Revenue : 0.13 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Aligned Genetics Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Aligned Genetics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩174 Mil. Aligned Genetics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩2,790 Mil. Aligned Genetics's annualized Revenue for the quarter that ended in Dec. 2024 was ₩22,452 Mil. Aligned Genetics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.13.


Aligned Genetics Debt-to-Revenue Historical Data

The historical data trend for Aligned Genetics's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aligned Genetics Debt-to-Revenue Chart

Aligned Genetics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.38 0.32 0.31 0.19

Aligned Genetics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.36 0.35 0.20 0.13

Competitive Comparison of Aligned Genetics's Debt-to-Revenue

For the Medical Devices subindustry, Aligned Genetics's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aligned Genetics's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aligned Genetics's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aligned Genetics's Debt-to-Revenue falls into.


;
;

Aligned Genetics Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Aligned Genetics's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(173.943 + 2789.6) / 15777.579
=0.19

Aligned Genetics's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(173.943 + 2789.6) / 22452.028
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Aligned Genetics Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aligned Genetics's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aligned Genetics Business Description

Traded in Other Exchanges
N/A
Address
28 Simindaero 327 beon-gil, Floor 2nd and 3rd, Dongan-gu Anyang-si, Gyeonggi-do, KOR, 14055
Aligned Genetics Inc is engaged in developing automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.

Aligned Genetics Headlines

No Headlines